PhoenixBio
Business Services · Japan · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3-4-1 Kagamiyama, Kagamiyama, Hiroshima,...Phone Number
+81 824310016Website
www.phoenixbio.co.jpRevenue
$11.3 MillionStock Symbol
6190Industry
About PhoenixBio
PhoenixBio Org Chart
Is PhoenixBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once PhoenixBio has new funding data
Product Launch: Get notified when PhoenixBio launches new products
Check out if PhoenixBio is spiking on competitors!
Earning: See what the market has to say on PhoenixBio recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
PhoenixBio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at PhoenixBio
Check if PhoenixBio has recently received funding, and reach out quickly before it becomes old news!
Click to see if PhoenixBio had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at PhoenixBio
Find 2 more new buyers
Company Profile Activity
Activity Insights
PhoenixBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PhoenixBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PhoenixBio.
PhoenixBio Tech Stack
A closer look at the technologies used by PhoenixBio
PhoenixBio News & Media
KMT Hepatech Announces Expansion of Staff and Operations in Edmonton, AB, Canada
EDMONTON, Alberta--(BUSINESS WIRE)--KMT Hepatech, Inc. (“KMT”), a part of PhoenixBio group, announced plans to expand staff and operations by providing services with PXB-Mouse® and starting the production of the PXB-Cells® – hepatocytes isolated from cDNA-uPA/SCID mice with highly humanized liver. The isolated fresh hepatocytes (PXB-Cells®) will be supplied to the clients to support researchers across a wide range of drug development fields, including hepatitis B (HBV) in vitro studies and DMPKKMT Hepatech Announces Strategic Investment From PhoenixBio
EDMONTON, Alberta--(BUSINESS WIRE)--KMT Hepatech, Inc. (“KMT”) announced today that it has reached an agreement to join efforts with PhoenixBio Co., Ltd. (PhoenixBio). Together they will advance the use of the cDNA-uPA/SCID mouse model with highly humanized liver to support researchers across a wide range of drug development fields. KMT will become a subsidiary of PhoenixBio group effective November 30, 2017. PhoenixBio plans to invest in KMT and expand its operations. The uPA/SCID mouse model
Top Business Services Companies
Frequently Asked Questions Regarding PhoenixBio
PhoenixBio Co., Ltd. specializes in contract testing services for drug development using PXB mice, which are the most widely used human liver cell chimeric mice globally. The company offers high-quality testing services and has successfully developed a method to freeze fresh human liver cells (PXB-cells) without compromising their functionality. Wi... Read More